2024/05/10 22:30:01 | |
---|---|
Price | |
4.151 USD | |
Difference | 1.38% (0.06) |
ISIN | US78423T2006 |
Symbol | SHLT |
Exchange | Nasdaq |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 62 EUR |
Benchmark | MSCI WORLD INDEX (STRD, UHD) |
Bid (Bid size) | 3.87 USD (200) |
Ask (Ask size) | 6.56 USD (200) |
Open | 4.151 USD |
High | 4.151 USD |
Low | 4.151 USD |
Close (prev. day) | 4.0945 USD |
VWAP | 4.151 USD |
Volume (pcs) | 565 |
Trading volume | 2,342.31 |
Number of trades | 18 |
Last size | - |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/04/26 | Global Equity Ratings | ||
2024/04/03 | Global Equity Ratings | ||
2024/03/13 | Global Equity Ratings | ||
2024/02/22 | Global Equity Ratings | ||
2024/02/14 | Global Equity Ratings |
2024/05/10 22:30:01 | |
---|---|
Price | |
4.151 USD | |
Difference | 1.38% (0.06) |
ISIN | US78423T2006 |
Symbol | SHLT |
Exchange | Nasdaq |
Currency | USD |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 62 EUR |
Benchmark | MSCI WORLD INDEX (STRD, UHD) |
Bid (Bid size) | 3.87 USD (200) |
Ask (Ask size) | 6.56 USD (200) |
Open | 4.151 USD |
High | 4.151 USD |
Low | 4.151 USD |
Close (prev. day) | 4.0945 USD |
VWAP | 4.151 USD |
Volume (pcs) | 565 |
Trading volume | 2,342.31 |
Number of trades | 18 |
Last size | - |
6m | 1Y | 3Y | |
Perf (%) | -51.34% | -54.39% | - |
Perf (abs.) | -4.38 | -4.95 | - |
Beta | 0.61 | 0.31 | 0.14 |
Volatility | 73.05 | 62.11 | - |
Ø price 5 days | Ø volume 5 days (pcs.) | 4.395 USD (3,340) |
Ø price 30 days | Ø volume 30 days (pcs.) | 5.293 USD (4,052) |
Ø price 100 days | Ø volume 100 days (pcs.) | 6.468 USD (3,553) |
Ø price 250 days | Ø volume 250 days (pcs.) | 8.478 USD (3,268) |
YTD High | date | 8.640 USD (2024/01/02) |
YTD Low | date | 4.060 USD (2024/05/09) |
52 Weeks High | date | 12.750 USD (2023/06/01) |
52 Weeks Low | date | 4.060 USD (2024/05/09) |
SHL TELEMEDICINE LTD. |
- - |
Ashdar Building, 90 Yigal Alon Street - 67891 Tel Aviv |
Telefon: +972-3-561-2212 |
Fax: +972-3-624-2414 |
E-mail: shl@shl-telemedicine.com |
SHL Telemedicine Ltd. engages in the development and market of advanced personal telemedicine solutions, which focuses on cardiovascular and related diseases. Its products and solutions include congestive heart failure, chronic obstructive pulmonary disease and cardiac monitoring services. It operates through the following geographical segments: Israel, Europe principally Germany, and Rest of the World. The company was founded by Yoram Alroy and Elon Shalev in 1987 and is headquartered in Tel Aviv, Israel. |
Erez Nachtomy | Chairman of Managing Board |
Amir Hai | Member of Executive Committee |
Yariv Alroy | Chairman of Supervisory Board |
Amir Lerman | Member of Supervisory Board |
Dvora Kimhi | Member of Supervisory Board |
Ido Nouberger | Member of Supervisory Board |
Nir Rotenberg | Member of Supervisory Board |
Yehoshua Abramowitz | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer